JOE BEHRMANN: Open Payments
NPI 1962414227 · ST. LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 9 payments from 4 companies in 2025. Trend: 2023 $339 · 2024 $406 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Alkermes, Inc. | 1 | $27 |
Products named: COBENFY, CAPLYTA, Auvelity, ARISTADA.
Industry payments across MO — which companies pay providers there.
